CorMedix, Inc. (CRMD)
7.19
-0.23
(-3.10%)
USD |
NASDAQ |
Oct 02, 16:00
7.185
0.00 (0.00%)
After-Hours: 20:00
CorMedix Profit Margin (Quarterly) : 25.50% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 25.50% |
| March 31, 2026 | 30.29% |
| December 31, 2025 | 10.90% |
| September 30, 2025 | |
| June 30, 2025 | 49.90% |
| March 31, 2025 | 52.82% |
| December 31, 2024 | 43.14% |
| September 30, 2024 | -24.24% |
| June 30, 2024 | -1.76K% |
| March 31, 2024 | |
| December 31, 2023 | |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | -27.64K% |
| September 30, 2022 | -100.8K% |
| June 30, 2022 | -35.70K% |
| March 31, 2022 | -92.56K% |
| December 31, 2021 | -13.81K% |
| September 30, 2021 | -22.49K% |
| June 30, 2021 | -56.50K% |
| March 31, 2021 | -8.17K% |
| December 31, 2020 | -10.93K% |
| September 30, 2020 | -7.10K% |
| June 30, 2020 | -23.06K% |
| Date | Value |
|---|---|
| March 31, 2020 | -7.50K% |
| December 31, 2019 | -21.39K% |
| September 30, 2019 | -8.85K% |
| June 30, 2019 | -1.97K% |
| March 31, 2019 | -3.16K% |
| December 31, 2018 | |
| September 30, 2018 | -2.75K% |
| June 30, 2018 | -112.6K% |
| March 31, 2018 | -43.90K% |
| December 31, 2017 | -11.15K% |
| September 30, 2017 | -16.30K% |
| June 30, 2017 | -3.78K% |
| March 31, 2017 | -19.18K% |
| December 31, 2016 | -5.26K% |
| September 30, 2016 | -20.51K% |
| June 30, 2016 | -29.62K% |
| March 31, 2016 | -9.95K% |
| December 31, 2015 | -16.88K% |
| September 30, 2015 | -13.06K% |
| June 30, 2015 | -3.45K% |
| March 31, 2015 | -17.56K% |
| December 31, 2014 | -2.61K% |
| September 30, 2014 | -9.61K% |
| June 30, 2014 | |
| March 31, 2014 | -137.0K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | -- |
| Eloxx Pharmaceuticals, Inc. | -- |
| BioStem Technologies, Inc. | -113.6% |
| Wave Life Sciences, Inc. | -3.05K% |
| Axsome Therapeutics, Inc. | -23.50% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 49.31% |
| Return on Assets | 25.99% |
| Return on Invested Capital | 39.96% |
| Gross Profit Margin (Quarterly) | 75.66% |
| Operating Margin (Quarterly) | 42.10% |
| Return on Net Operating Assets | 37.27% |